“Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)-A Randomized Controlled Trial”, Diabetes Care 2023;46:463–468. This evidence concerns the gene INS and type 2 diabetes mellitus.